asked to complete a Kerrigan 13-symptom questionnaire (Table 1) at their first preoperative visit, during initial consultation. The Kerrigan 13-symptom questionnaire was developed by an expert panel and patient focus group, 1 and it was selected for this particular study because it is condition specific. The goal of the questionnaire was to generate data that would provide average values for symptoms that caused the patient distress, which could then be compared to the patient's assessment of postoperative severity of the same symptoms. In the Kerrigan system, a value of 0 is assigned to a symptom that is noted "all the time," 25 is "most of the time," 50 is "some of the time," 75 is "a little of the time," and 100 is "none of the time." Symptoms about which the patients were queried included (1) upper back pain; (2) difficulty finding bras and clothes that fit; (3) headaches; (4) breast pain; (5) lower back pain; (6) rashes and/or itching; (7) painful bra strap grooves; (8) difficulty participating in sports; (9) neck pain; (10) shoulder pain; (11) difficulty running; (12) pain or numbness in the hands; and (13) arm pain.
Those patients who elected to undergo surgery were seen one day, one week, and three weeks postoperatively for follow-up. (The sutures were removed at the threeweek visit.) The next postoperative visit was then scheduled for approximately 10 weeks after the procedure, at which time the same Kerrigan 13-symptom questionnaire was administered again. If a patient was unable or unwilling to present for the 10-week follow-up appointment because of distance, she was asked to complete the survey at her three-week visit. We found that patients generally did not return for the second visit if there were no complications or if the patient lived out of town. The mean follow-up time for administration of the survey was eight weeks postoperatively.
In total, 260 patients from 2003-2009 underwent vertical reduction mammaplasty by the senior author (CA) during the study period and participated in both the preand postoperative questionnaires. Ten percent of the patients in the consecutive series failed to complete the postoperative questionnaire and were therefore excluded from the study. The medical chart of each patient was reviewed and the type of procedure, the amount of tissue removed, and any complications were noted.
For the purpose of the study, we separated primary mammaplasty patients into four different categories based on the amount of excised tissue: mild (up to 300 g), moderate (300-700 g; Figure 1 ), marked (700-1200 g; Figure 2 ), and gigantic (more than 1200 g; Figure 3 ). (The clinical photos demonstrate the preoperative condition and early postoperative results, pending longer-term follow-up in the authors' second study.) Patients undergoing revision mammaplasties were separated into a category of their own. Of the 260 patients in the study, 13% fell into the mild category, 27% into the moderate, 40% into the marked, and 14% into the gigantic; 6% were revisions of previous reductions (Table 2) .
Preoperative evaluation of each patient's suitability for mammaplasty included an assessment of skin quality and the presence of subdermal veins, areola size, quality of breast tissue, nipple position, presence of axillary rolls, and any asymmetry. A superior pedicle vertical reduction mammaplasty was the only technique implemented for all 260 patients, in accordance with the author's preference in treating breast hypertrophy. During deepithelialization, the flap was consistently extended to 2 cm below the areola, but the width and length were variable and depended on the degree of ptosis observed in each patient. Liposuction was performed on 234 patients (90%), to varying degrees, to decrease the prominence of axillary rolls. 
ReSultS
The average amount of tissue excised from each breast was 850 g. The smallest resection was 225 g and the largest resection totaled 2293 g from each side. The same amount was excised from each side unless the patient demonstrated asymmetry. For patients who underwent liposuction, the average amount of aspirate was 245 cc; the smallest amount suctioned was 50 cc and the largest amount was 800 cc ( Table 3 ). The patients' body mass index ranged from 19.2-48.1, with an average of 30.1. The responses of each patient were tallied to find an average rating for each hypertrophy symptom. Preoperatively, patients experienced difficulty finding bras or clothes to fit, difficulty running, painful bra strap grooves, difficulty participating in sports, lower back pain, shoulder pain, neck pain, and upper back pain in the range of all the time (0) and most of the time (25), on average. The issues that were reported, on average, as present most of the time (25) to some of the time (50) were intertrigo and breast pain. Patients most often reported experiencing arm pain, headaches, and pain or numbness in hands some of the time (50) to a little of the time (75). No issues were reported to average between a little of the time (75) and none of the time (100; Table 4 ).
When the pre-and postoperative responses were compared, it was found that patients experienced the largest Other issues that showed improvement postoperatively were intertrigo (97 to 35; Δ 62), breast pain (85 to 40; Δ 45), arm pain (100 to 58; Δ 42), headaches (100 to 65; Δ 35), and pain or numbness in hands (100 to 72; Δ 28). The full results are shown in Table 4 .
In addition to the symptomatic relief that was reported almost unanimously by patients in the study, the aesthetic results were assessed and patient satisfaction seemed to vary according to each patient's preoperative condition. The same survey was administered preoperatively and postoperatively. The results were computed by averaging the item scores and linearly transforming the average to a 0-100 scale. For example, larger-breasted patients (those in the gigantic category) were less critical of minor postoperative imperfections and asymmetry, whereas patients who had only mild preoperative hypertrophy were less likely to overlook minor imperfections. Various calculations were made from the values reported for the preoperative and postoperative symptoms.
All subsequently calculated values were determined based on the variability in the average questionnaire response to different symptoms, rather than individual patients. The average preoperative value for all symptoms was 27.38, and the average postoperative value for all symptoms was 96.615. When the preoperative responses were treated as a control group (without intervention) and the postoperative responses were treated as the intervention (or event) group, a t-value of 46.022 with a P-value of < .001 was obtained between the two groups. Other values calculated included a relative benefit increase of 2.528, an absolute benefit increase of 69.230, and a number needed to treat of 0.014. This demonstrates a statistically significant improvement in patient symptoms, implying a benefit to the surgery. 
diScuSSion
Our six-year study had the significant benefit of being performed exclusively by one board-certified plastic surgeon, which leads to less operator-dependent variability compared with studies containing a larger pool of participating surgeons. 2 All patients included in this study completed both the preoperative and postoperative surveys. In contrast, Davis's study reported as many as 780 patients, which is quite impressive, but it had only a 52% response rate to the postoperative survey. 3 Our comparison of preoperative and postoperative survey results, which represents a departure from the postoperative-only original implementation of the Kerrigan questionnaire, 1 allowed for more specific quantification of patient satisfaction.
Schnur et al documented the same 13 symptoms evaluated in our study, but the extent to which each symptom affected each patient's life went unmeasured. 2 In another study, preoperative symptoms were documented based on severity, with the patients categorizing themselves into one of four groups, as we did 4 ; however, for postoperative results, the authors employed a different evaluation system to record each patient's symptomatic resolution. Although that study provided useful information, we believe that our study allowed less room for error and/or misinterpretation of the data, since we addressed postoperative issues in the same format as preoperative issues, resulting in an identical scoring system at both time points. Patient confusion was thus minimized through a standardized grading system.
Outcome studies for reduction mammaplasty are prevalent in the literature, and our results generally reinforce the findings of these previous reports. One study documented a 93% symptomatic improvement for moderate to severe bra strap grooves, neck and shoulder pain, and upper back pain. 5 Another reported that all patients (100%) experienced reduction of their preoperative pain symptomatology following mammaplasty. 6 In terms of technique, Dabbah et al reported a particularly high symptomatic improvement rate of 97% regardless of the mammaplasty technique employed 7 ; the same authors reported 90% improvement in another multipletechnique study. 8 Makki et al documented a 91% postoperative symptomatic improvement in 71% of their patients with inverted-T reduction technique. 9 Another study clearly documented improvement in all evaluated preoperative symptoms, both physical and psychosocial, for all patients who underwent vertical reduction mammaplasty. 10 Together, these studies confirm the well-documented benefits of reduction mammaplasty, leaving us to focus increasingly on the patients' aesthetic satisfaction while maintaining the standard of symptomatic and psychosocial relief. Overall, vertical reduction mammaplasty is beneficial for all types of breast hypertrophy and practically eliminates the need for nipple and areolar grafting, while minimizing operating time and offering a high degree of patient satisfaction.
When acknowledging surgical candidates, one must remember that once the symptom threshold is reached, the bra size is not the critical factor. Both the Kerrigan study and our own study have shown us that breast size has a weak association with health burden. In other words, the relationship between increasing size and increasing symptoms is not a direct one after a patient's breasts become large enough to cause symptomatic pain in the first place.
Of the 260 patients in our study, patients from all categories of hypertrophy were included, with 14% from the gigantic category and 40% in the marked group. Excisions ranged from 225 g to as much as 2293 g from each side. Asymmetry was better tolerated by patients from the marked and gigantic categories than the mild or moderate category. Patients in the larger excision groups were more satisfied with their results than patients from the mild or moderate group, with the idea being that patients from the larger categories experienced a more significant overall change in appearance and were more willing to overlook imperfections and complications. Pers et al documented the correlation between patient expectations of the procedure and how they subsequently interpreted their outcomes, noting that the average age of patients who felt that their expectations were not fully met was eight years younger than the median age of patients in his study; in essence, older patients were more satisfied with their results.
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Although age was not a demographic evaluated in our current study, one can appreciate the implication of the Pers results, which reinforce the idea that expectations often dictate postoperative satisfaction. Although our 35% complication rate may seem high, this percentage is similar to 33% and 45% rates recorded in previous studies.
12,7 Our complication rate is described more specifically in Part II of this study, which is pending publication. Our most common complications were fat necrosis, vertical limb breakdown, and areola depression. In the studies mentioned above, Brown et al documented delayed wound healing (16%) and superficial infection (8%) as the most frequent complications, 9 whereas Dabbah et al noted fat necrosis/infection at a rate of 22%.
1 Only 3.3% of our patients required a second procedure for dehiscence, whereas Brown's previous study had a secondary procedure rate of nearly 9%.
concluSionS
This study documents the results from a cohort of vertical reduction mammaplasty patients by comparing their preoperative and postoperative physical and psychosocial symptoms as reported through a Kerrigan questionnaire. Our patients reported complete postoperative resolution of three symptoms (arm pain, headaches, and pain or numbness in the hands), and all other symptoms showed a significant improvement, with patients reporting a major reduction of symptoms postoperatively. The technique itself is not difficult to learn and is beneficial for all types of breast hypertrophy. In comparison to traditional techniques, the vertical reduction mammaplasty reduces operating time and practically eliminates the need for free nipple and areolar grafting. This result leads to a high degree of patient and surgeon satisfaction, both with the aesthetic results and with symptomatic resolution.
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